In addition, we examined REG4 expression in normal ovarian tissue, benign and borderline ovarian tumors, and primary and metastatic cancers, and compared our findings with the clinicopathological and prognostic parameters of tumors surgically resected from the patients with ovarian cancer. This evidence concerns the gene REG4 and metastatic malignant neoplasm.